| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4031130 | Ophthalmology | 2006 | 9 Pages |
Abstract
Verteporfin photodynamic therapy combined with intravitreal triamcinolone may improve the outcome of standard verteporfin photodynamic therapy in the treatment of choroidal neovascularization secondary to AMD. A significant improvement in VA was observed in a majority of treated patients and was maintained during the maximum follow-up. In addition, retreatment rates were lower than anticipated.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Albert J. MD, Ursula MD,